No it isnt but honestly, has anything been encouraging along the likes of the many failed covid treatment companies that got flushed?
Other than one major run to the 70s it seems weve never been able to mimic the trading patterns of those stocks that were clearly blowing hot air re their research.
Now that theyve all gone bye bye its just us left, along with a handful other smallcaps, if that much.
This might be very controversial but when the first fda pr was put out i became very skeptical of the intent of it, ie was it vaguely worded intentionally to precipitate a selloff???
Now with this latest kerfuffle involving bmt and the other reddit guy re the endpoint choice, my skepticism of mf's "intent" has once again reared its ugly head.
Lets be honest, mf's true loyalty is to revive and its success, and likely to canaccord......NOT LONGS!!!
Its their cash infusion thats making this possible after all.
Always expected Longs positions would be targeted by mm's, traders, Canacc and the rest of the usual suspects..........but from within revive also???
Certainly hope this is not the case and its simply me being a bit paranoid late in the game.
Market Data 
Markets 
AI
